Al-saraireh YM, Alshammari FO, Hassan HA, Jaradat JH, Al-abadleh AA, Satari AO, Al-sarayreh SA, Al-dalain SM, Al-Qtaitat A, Al Shuneigat JM, Hareedy MS

Breast Cancer: Targets and Therapy 2026, 18:612743

Published Date: 7 July 2026

Review

Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity

Yi G, Deng L, Su L, Jie H, Huang C, Wang Y

Breast Cancer: Targets and Therapy 2026, 18:617698

Published Date: 30 June 2026

Review

Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation

Abdel-Razeq H

Breast Cancer: Targets and Therapy 2026, 18:618067

Published Date: 24 June 2026

Review

Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation

Ma X, Dang S, Wang H, Xia L, Ma P, Qi Y

Breast Cancer: Targets and Therapy 2026, 18:605051

Published Date: 24 June 2026

Original Research

Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer

Tan Y, Zeng C, Zhao J, Zhao W, Jiang H, Wang J, Ma F

Breast Cancer: Targets and Therapy 2026, 18:574628

Published Date: 23 June 2026

Original Research

SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC

Chen P, Xu J, Liang Y, Mu J, Feng W, Liu J, Li B

Breast Cancer: Targets and Therapy 2026, 18:606599

Published Date: 22 June 2026

Original Research

Risk Factors and Prognosis Analysis of Infiltrating Micropapillary Carcinoma of Breast: A Retrospective Study

He P, Sha Y, Lu Y, Li T, Li X, Liu Y, Pang H, Han J, Yuan Q

Breast Cancer: Targets and Therapy 2026, 18:612948

Published Date: 19 June 2026

Original Research

Induced Electric Fields Inhibit Breast Cancer Growth and Metastasis and Modulate the Immune Tumor Microenvironment

Charan M, Jones TH, Ahirwar DK, Acharya N, Subramaniam VV, Shilo K, Ganju RK, Song JW

Breast Cancer: Targets and Therapy 2026, 18:604098

Published Date: 16 June 2026

Original Research

Willingness to Undergo Corrective Surgery After Breast-Conserving Surgery in Chinese Patients with Breast Deformities: A Single-Center Study

Zhang J, Wu Z, Gao J, Gao F, Guo F

Breast Cancer: Targets and Therapy 2026, 18:614465

Published Date: 12 June 2026

Review

HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies

Shi H, Feng Y, Guo T, Shou W, Li Y

Breast Cancer: Targets and Therapy 2026, 18:612951

Published Date: 12 June 2026

Retraction

Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis [Retraction]

Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y

Breast Cancer: Targets and Therapy 2026, 18:631806

Published Date: 12 June 2026

Original Research

Pan-Cancer Analysis of a Depression-Related Gene Signature Identifies an Immunosuppressive Tumor Microenvironment and Links to Immunotherapy Response in Breast Cancer

Chen G, Yin B, Khan M, Yang Y, Sun Q, Zhang T, Hu H, Lin J

Breast Cancer: Targets and Therapy 2026, 18:578930

Published Date: 12 June 2026

Original Research

Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study

Zhou C, Guo Y, Meng Z, Wan K, Qin J, Wang Y

Breast Cancer: Targets and Therapy 2026, 18:563533

Published Date: 9 June 2026

Original Research

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan

Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, Chen JH, Huang TC

Breast Cancer: Targets and Therapy 2026, 18:595563

Published Date: 3 June 2026

Review

Artificial Intelligence-Driven Quantitative HER2 Scoring and Spatial Bystander Effect Modeling for ADC Response Stratification in HER2-Low Breast Cancer

Liu J, Zhang X

Breast Cancer: Targets and Therapy 2026, 18:605985

Published Date: 28 May 2026

Original Research

Management of HER2+ Breast Cancer with and without Brain Metastases in Saudi Arabia: Literature Insights and an Expert Survey of Current Practices

Kullab S, Refae A, Altwairgi A, Abusanad A, Elsamany S, Abdelhafiez NA, Basulaiman B, Zahralliyali A, Alshangiti AA, Al-mubarak M, Alwbari A, Alharbi A, Osman A, Kiwan H, Alaklabi S

Breast Cancer: Targets and Therapy 2026, 18:599184

Published Date: 27 May 2026

Original Research

Plasma Vitamin C Levels in Distinguishing Benign from Malignant Breast Tumors and Clinical Correlates in Chinese Patients: A Cross-Sectional Study

Jiang S, Gao D, Yin Y, Sun Z, Ding T, He Y, Zhang Y, Li Y, Dong M

Breast Cancer: Targets and Therapy 2026, 18:579640

Published Date: 27 May 2026

Original Research

Postoperative Complications Following Neoadjuvant Therapy Across Different Oncoplastic Breast Surgery Techniques: A Retrospective Comparative Study in Breast Cancer Patients

Kulturoglu MO, Dogan L, Gulcelik MA

Breast Cancer: Targets and Therapy 2026, 18:607172

Published Date: 27 May 2026

Original Research

Characterization and Cytotoxicity of West Java Coffee Extracts, Chlorogenic Acid, Caffeine on MDA-MB-231, MCF-7 Cell Lines, and Their Impact on MYC and AXIN2 Wnt Pathway Gene Expression

Aborziza M, Zuhrotun A, Novianto A, Amalia R, Fakih TM, Muchtaridi M

Breast Cancer: Targets and Therapy 2026, 18:606305

Published Date: 26 May 2026

Original Research

Differentiation of Benign and Malignant BI-RADS 4–5 Breast Lesions Using Ultrasound Localization Microscopy–Derived Microvascular Biomarkers: A Prospective Study

Wei W, Lu W, Zhou W, Zhang D, Xu X, Zhou J, Gao Y, Duan Y, Zhang C

Breast Cancer: Targets and Therapy 2026, 18:596312

Published Date: 23 May 2026

Original Research

The Regulatory Mechanism and Value in Early Diagnosis and Prognosis Assessment of miR-4448 in Breast Cancer

Zhang Z, Liu Z, Li C, Wang F, Tian Z, Liu X, Yu Z

Breast Cancer: Targets and Therapy 2026, 18:592003

Published Date: 21 May 2026

Review

A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection

Liu J, Peng X, Yang Y, Huang X, Du Y, Liu K

Breast Cancer: Targets and Therapy 2026, 18:600575

Published Date: 20 May 2026

Original Research

Hsa_circ_0000520 Promotes Invasion and Metastasis of Breast Cancer Cells by Targeting HSP90AA1

Cai M, Lu T, Lv S, Zheng Z, Gao L, Wang H, Dong X

Breast Cancer: Targets and Therapy 2026, 18:600770

Published Date: 18 May 2026

Original Research

Integrating Ultrasound and DCE-MRI Improves Accuracy in Differentiating Breast Adenosis from Carcinoma

Zhang Y, Fan Y, Yao X, Zhou H, Han D, Xiao Y, Zhong P, Fang J

Breast Cancer: Targets and Therapy 2026, 18:604929

Published Date: 14 May 2026

Original Research

The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer

Tian C, Qiu J, Fan Y, Yu H, Liu S

Breast Cancer: Targets and Therapy 2026, 18:595222

Published Date: 12 May 2026

Original Research

ADPB Sensitivity in Breast Cancer is Correlated with LAT1 Expression: An in vitro Study of a Novel Theranostic Candidate

Kusumahstuti KP, Holik HA, Bashari MH, Achmad A, Shamsuddin S, Kartamihardja AHS

Breast Cancer: Targets and Therapy 2026, 18:564513

Published Date: 7 May 2026

Review

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review

Abbaspour M, Esmaeil N, Akbari V, Ghoreishi M, Rafiepoor H

Breast Cancer: Targets and Therapy 2026, 18:588323

Published Date: 5 May 2026

Original Research

Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study

Zhou S, Yao R, Zhang M, Jiang M, Liu J, Li M, Ma F, Pan B, Li Q

Breast Cancer: Targets and Therapy 2026, 18:589939

Published Date: 4 May 2026

Review

Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer

Obeagu EI

Breast Cancer: Targets and Therapy 2026, 18:603801

Published Date: 1 May 2026

Original Research

Uncertainty-Aware Machine Learning for Predicting Axillary Lymph Node Metastasis Using Breast MRI

Ünal S, Gürfidan R

Breast Cancer: Targets and Therapy 2026, 18:599211

Published Date: 1 May 2026

Original Research

Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer

Pan H, Huang Z, Li A, Li M, Li Y, Lin Y, Cai J

Breast Cancer: Targets and Therapy 2026, 18:577378

Published Date: 30 April 2026

Original Research

Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer

Zhao J, Gou Y, Wang Y, Li Y, Ma H, Xing Y, Peng H, Guo C

Breast Cancer: Targets and Therapy 2026, 18:554836

Published Date: 29 April 2026

Original Research

Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNA

Park KT, Lee NR, Jeong YJ

Breast Cancer: Targets and Therapy 2026, 18:599533

Published Date: 28 April 2026

Original Research

Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer

Jiang X, Wang S, Wei Q, Yang Y, Chen Y, Chen S

Breast Cancer: Targets and Therapy 2026, 18:586715

Published Date: 20 April 2026

Original Research

From Axillary Lymph Node Dissection to Sentinel Node Biopsy in Breast Cancer: A 23-Year Population-Based Large-Sample Study with Long-Term Survival Outcomes

Mangone L, Marinelli F, Bisceglia I, Braghiroli MB, Neri A, Morabito F, Pinto C, Ragazzi M, Ferrari G, Coiro S, Cenini E

Breast Cancer: Targets and Therapy 2026, 18:573154

Published Date: 17 April 2026

Original Research

LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p

Xiong M, Yang Q, Cheng L, Yu L, Hu Y

Breast Cancer: Targets and Therapy 2026, 18:596228

Published Date: 16 April 2026

Original Research

Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study

Birsin Z, Güren AK, Aliyev V, Guliyev M, Jeral S, Cebeci S, Çerme E, Günaltılı M, Abbasov H, Çiçek E, Atak S, Sarı M, Demirci NS, Alan Ö

Breast Cancer: Targets and Therapy 2026, 18:598598

Published Date: 15 April 2026

Original Research

HER2 Overexpression in Invasive Breast Carcinoma in the Democratic Republic of Congo and its Association with Selected Clinicopathological Characteristics

Ilunga Nday G, Ilunga Banza M, Umpungu AN, Kabamba Nzaji M, Moyambe JNT

Breast Cancer: Targets and Therapy 2026, 18:600288

Published Date: 15 April 2026

Original Research

Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression

Behar J, Shiang C, Dolcen DN, Bennett LB, DeVilbiss AW, Matossian MD, Chan IS, Nanda R, Conzen SD, Lafin JT

Breast Cancer: Targets and Therapy 2026, 18:569936

Published Date: 14 April 2026

Original Research

Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance

Tsunoda A, Mizuno T, Nakamori S, Ichikawa M, Tono Y, Saito K, Tawara I

Breast Cancer: Targets and Therapy 2026, 18:596107

Published Date: 13 April 2026

Original Research

Analysis of Factors Related to Lymph Node Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Correlation Between Plasma Exosomal Circular RNA and Metastasis

Ma S, Huang Y, Yang Q, Liu X, Zhang Z, Yan B

Breast Cancer: Targets and Therapy 2026, 18:588196

Published Date: 9 April 2026

Original Research

Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer

Sharaf B, Seif A, Bani Hani H, Alhasan M, Khader R, Al-Yag’oub M, Ghanem A, Bani Ata J, Ajlouni B, Jawarneh Q, Jaffal A, Tamimi F, Jehad S, Al-Abdallat H, Mahafdah O, Abdel-razeq H

Breast Cancer: Targets and Therapy 2026, 18:559555

Published Date: 9 April 2026

Original Research

Peripheral Blood IL-6 and STAT3 Gene Expression as Biomarkers Associated with Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer: A Prospective Cross-Sectional Study

Özdemir K, Muhtaroğlu A, Kamburoğlu MB, Guney Eskiler G, Özman Gökçe Z, Kocer B

Breast Cancer: Targets and Therapy 2026, 18:593138

Published Date: 8 April 2026

Original Research

IFI44 Orchestrates an IL-10–Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signature

Wu J, Yi W, Liu M, Li Y, Zhou B, Wu Z, Cao W, Shi Q, Cai X, Xiong H

Breast Cancer: Targets and Therapy 2026, 18:579301

Published Date: 8 April 2026